Table 1.
Summary of demographic and clinical characteristics of the study cohort.
| Variables | Pneumococcal Empyema Patients |
|---|---|
| Demographic characteristics | |
| Sex (male) a | 5/8 (62.5%) |
| Age (years) b | 5.1 (3.1) |
| Medical history | |
| Asthma a | 2/8 (25.0%) |
| Pneumococcal vaccination status a | |
| PCV | 6/8 (75.0%) |
| PCV 10 | 1/8 (12.5%) |
| PCV 13 | 1/8 (12.5%) |
| Clinical data | |
| Treatment prior to admission a | |
| Antibiotics | 3/8 (37.5%) |
| Antipyretic | 2/8 (25.0%) |
| Hospital length of stay (days) b | 21.2 (16.4) |
| PICU (days) b | 8.0 (3.8) |
| Respiratory support a | 2/8 (25.0%) |
| Oxygen a | 4/8 (50.0%) |
| Urokinase a | 5/8 (62.5%) |
| Blood test | |
| Leukocytes (c/mm3) b | 17,971.2 (5751.5) |
| Procalcitonin (ng/mL) b | 253.5 (565.4) |
| Pleural fluid test | |
| Glucose (mg/dL) b | 19.4 (25.2) |
| Proteins (g/dL) b | 5.0 (1.0) |
| Course and outcome | |
| Course a | |
| Necrotizing pneumonia | 4/8 (50.0%) |
| Sepsis | 1/8 (12.5%) |
| Sequelae a | |
| Pneumatocele | 1/8 (12.5%) |
| Exitus | 1/8 (12.5%) |
a number of patients (%). b mean (standard deviation, SD); PICU: paediatric intensive care unit; PCV: Pneumococcal conjugate vaccine.